Instructional Course

International

Clinical Practice (assessment, diagnosis, treatment, knowledge translation/EBP, implementation science, program development)

COVID-19

IC34: Psychological and neuropsychological sequela derived from the COVID-19 pandemic

Monday, November 7, 2022

1:30 PM – 5:30 PM

Presenter(s)

Stephanie A. Kolakowsky-Hayner, PhD, CBIST, FACRM

Director of Research and Clinical Outcomes
Good Shepherd Rehabilitation Network
Royersford, Pennsylvania, United States

Slides
Fofi Constantinidou, PhD, CCC-SLP, CBIS, FACRM (she/her/hers)

Professor and Center Director
Center for Applied Neuroscience, University of Cyprus
Nicosia, Nicosia, Cyprus
Amanda Sacks-Zimmerman, Ph.D., ABPP-CN

Asssitant Professor
Weill Cornell Medicine
New York, New York, United States
MC

Melinda A. Cornwell, PhD

fellow of Neurorehabilitation Psychology
Weill Cornell Medicine
New York, NY, United States
Juan Carlos C. Arango Lasprilla, PhD

Chief Research Officer for Latin America and Spain
Giunti Psychometrics
Bilbao, Pais Vasco, Spain
Thomas F. Bergquist, Ph.D., ABPP-Cn, FACRM

Associate Professor
Mayo Clinic
Rochester, Minnesota, United States
MT

Mari Tobita, MD

Physician Specialist
Rancho Los Amigos National Rehabilitation Center
Downey, California, United States

Social distancing and sheltering in place due to COVID-19 has led to changes in and disruption of individuals’ mental wellbeing and sleep schedules, similar to those observed following previous natural disasters. Additionally, fear of the disease, changes in lifestyle, and social isolation created unprecedented circumstances and an increase in health care challenges including mental health concerns. The purpose of this instructional course is to describe the psychological and neuropsychological sequela from COVID-19 internationally, provide recommendations on how to assess neuropsychological symptoms associated with post acute COVID syndrome (PCS) and treatment recommendations based on phenotypes.

Learning Objectives:

Explain what COVID-19 is and enumerate how it has impacted the general population
Characterize post COVID acute syndrome including at least 2 phenotypes and explain how to assess of post COVID acute syndrome identifying an appropriate battery of tests for post COVID acute syndrome
Review risk factors for increased Long-COVID neurobehavioral symptoms and rationalize treatment of post COVID acute syndrome
Describe rationale for integrated CR/CBT for treating the neuropsychological symptoms in post COVID acute syndrome
Describe treatment components of integrated treatment and provide case examples of the use of integrated treatment in this population